Literature DB >> 19946273

Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development.

Stephen Malin1, Shane McManus, César Cobaleda, Maria Novatchkova, Alessio Delogu, Philippe Bouillet, Andreas Strasser, Meinrad Busslinger.   

Abstract

STAT5 and interleukin 7 (IL-7) signaling are thought to control B lymphopoiesis by regulating the expression of key transcription factors and by activating variable (V(H)) gene segments at the immunoglobulin heavy-chain (Igh) locus. Using conditional mutagenesis to delete the gene encoding the transcription factor STAT5, we demonstrate that the development of pro-B cells was restored by transgenic expression of the prosurvival protein Bcl-2, which compensated for loss of the antiapoptotic protein Mcl-1. Expression of the genes encoding the B cell-specification factor EBF1 and the B cell-commitment protein Pax5 as well as V(H) gene recombination were normal in STAT5- or IL-7 receptor alpha-chain (IL-7Ralpha)-deficient pro-B cells rescued by Bcl-2. STAT5-expressing pro-B cells contained little or no active chromatin at most V(H) genes. In contrast, rearrangements of the immunoglobulin-kappa light-chain locus (Igk) were more abundant in STAT5- or IL-7Ralpha-deficient pro-B cells. Hence, STAT5 and IL-7 signaling control cell survival and the developmental ordering of immunoglobulin gene rearrangements by suppressing premature Igk recombination in pro-B cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19946273      PMCID: PMC2956121          DOI: 10.1038/ni.1827

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  50 in total

1.  Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow.

Authors:  Hideya Igarashi; Sophia C Gregory; Takafumi Yokota; Nobuo Sakaguchi; Paul W Kincade
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

2.  Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis.

Authors:  Thorsten Decker; Marina Pasca di Magliano; Shane McManus; Qiong Sun; Constanze Bonifer; Hiromi Tagoh; Meinrad Busslinger
Journal:  Immunity       Date:  2009-04-02       Impact factor: 31.745

3.  The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation.

Authors:  S K Ye; Y Agata; H C Lee; H Kurooka; T Kitamura; A Shimizu; T Honjo; K Ikuta
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

4.  Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene.

Authors:  Michael Schebesta; Peter L Pfeffer; Meinrad Busslinger
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

5.  Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5.

Authors:  V Sexl; R Piekorz; R Moriggl; J Rohrer; M P Brown; K D Bunting; K Rothammer; M F Roussel; J N Ihle
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

6.  Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway.

Authors:  H E Fleming; C J Paige
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

7.  Functional assessment of precursors from murine bone marrow suggests a sequence of early B lineage differentiation events.

Authors:  K S Tudor; K J Payne; Y Yamashita; P W Kincade
Journal:  Immunity       Date:  2000-03       Impact factor: 31.745

8.  Stepwise activation of the immunoglobulin mu heavy chain gene locus.

Authors:  D Chowdhury; R Sen
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

9.  Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development.

Authors:  Malay Mandal; Sarah E Powers; Kyoko Ochiai; Katia Georgopoulos; Barbara L Kee; Harinder Singh; Marcus R Clark
Journal:  Nat Immunol       Date:  2009-09-06       Impact factor: 25.606

10.  The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7.

Authors:  Juli P Miller; David Izon; William DeMuth; Rachel Gerstein; Avinash Bhandoola; David Allman
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

View more
  119 in total

1.  Turning transcription on or off with STAT5: when more is less.

Authors:  Michael A Farrar; Lynn M Heltemes Harris
Journal:  Nat Immunol       Date:  2011-11-16       Impact factor: 25.606

2.  Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.

Authors:  Ildiko Györy; Sören Boller; Robert Nechanitzky; Elizabeth Mandel; Sebastian Pott; Edison Liu; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2012-03-19       Impact factor: 11.361

3.  A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.

Authors:  Suchita Hodawadekar; Kyoungsook Park; Michael A Farrar; Michael L Atchison
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

4.  SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation.

Authors:  Thang Van Nguyen; Pornpimon Angkasekwinai; Hong Dou; Feng-Ming Lin; Long-Sheng Lu; Jinke Cheng; Y Eugene Chin; Chen Dong; Edward T H Yeh
Journal:  Mol Cell       Date:  2012-01-27       Impact factor: 17.970

5.  Integrated signaling in developing lymphocytes: the role of DNA damage responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

6.  Novel mechanism of tumor suppression by polarity gene discs large 1 (DLG1) revealed in a murine model of pediatric B-ALL.

Authors:  Gabriel J Sandoval; Daniel B Graham; Grzegorz B Gmyrek; Holly M Akilesh; Keiko Fujikawa; Benedicte Sammut; Deepta Bhattacharya; Shuba Srivatsan; Alfred Kim; Andrey S Shaw; Katherine Yang-Iott; Craig H Bassing; Eric Duncavage; Ramnik J Xavier; Wojciech Swat
Journal:  Cancer Immunol Res       Date:  2013-10-07       Impact factor: 11.151

7.  Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.

Authors:  Yong Wang; Cara C Schafer; Kenneth P Hough; Sultan Tousif; Steven R Duncan; John F Kearney; Selvarangan Ponnazhagan; Hui-Chen Hsu; Jessy S Deshane
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

8.  Cutting edge: cell-autonomous control of IL-7 response revealed in a novel stage of precursor B cells.

Authors:  Gabriel J Sandoval; Daniel B Graham; Deepta Bhattacharya; Barry P Sleckman; Ramnik J Xavier; Wojciech Swat
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

Review 9.  Lymphocyte development: integration of DNA damage response signaling.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Adv Immunol       Date:  2012       Impact factor: 3.543

10.  A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis.

Authors:  Olivia L Francis; Terry-Ann M Milford; Shannalee R Martinez; Ineavely Baez; Jacqueline S Coats; Karina Mayagoitia; Katherine R Concepcion; Elizabeth Ginelli; Cornelia Beldiman; Abigail Benitez; Abby J Weldon; Keshav Arogyaswamy; Parveen Shiraz; Ross Fisher; Christopher L Morris; Xiao-Bing Zhang; Valeri Filippov; Ben Van Handel; Zheng Ge; Chunhua Song; Sinisa Dovat; Ruijun Jeanna Su; Kimberly J Payne
Journal:  Haematologica       Date:  2015-11-26       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.